It is in agreement with our studies showing significant upregulation of the BRCA1-Δex11 in neural precursors in AD, which was particularly well pronounced upon induction of oxidative DNA damage with doxorubicin (Wezyk et al. 2018). This evidence concerns the gene BRCA1 and Alzheimer disease.